An investigational drug aimed at preventing strokes significantly reduced the ri...
The US Food and Drug Administration (FDA) has granted priority review for B...
Despite the shift towards artificial intelligence (AI) in drug discovery and de...
Novartis’ remibrutinib met all the primary and secondary endpoints at 12 weeks ...
AstraZeneca has posted a profit after tax of $1.37bn for the third quarter (Q3)...
Bayer has expanded a drug discovery research partnership with Recursion Pharmac...
The European Commission (EC) has granted approval for Daiichi Sankyo’s Vanflyta...
The US Food and Drug Administration (FDA) has granted approval for Takeda’s Adz...
Eli Lilly has substantiated its desire to acquire radiopharmaceutical company P...
The US Food and Drug Administration (FDA) has granted accelerated approval to t...
It isn’t often that pharmaceutical advancements break out of laboratories to be...
As Massachusetts biotech companies face dwindling investments, it appears that t...
After decades in use, heart stents finally beat placebo. It took a bold researcher.
Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a la...
How STAT's First Opinion section is trying to encourage more productive debate o...
An expert panel that advises the United Kingdom on vaccine policy has recommende...
